When did CRINETICS PHARMACEUTICALS IN (CRNX) report earnings last quarter?
CRINETICS PHARMACEUTICALS IN (CRNX) last reported earnings on 2/26/2026.
CRINETICS PHARMACEUTICALS IN (CRNX) Earnings History & Surprises
NASDAQ:CRNX • US22663K1079
Current stock price
38.62 USD
+0.29 (+0.76%)
At close:
38.0946 USD
-0.53 (-1.36%)
After Hours:
CRNX Earnings overview
Past quarterly earnings results for CRINETICS PHARMACEUTICALS IN (CRNX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.25
- Revenue Estimate
- 8.685M
Last Reported
Most Recent- Release Date
- Feb 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$1.29
- EPS Surprise
- 7.51%
- Revenue Surprise
- 27.48%
Beat Rate
Last 8 Quarters 38%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.29 | -1.39 | 7.51% | -46.59% | 6.161M | 4.833M | 27.48% | - |
| Q3 2025 | -1.38 | -1.28 | -7.76% | -43.75% | 143K | 370.892K | -61.44% | - |
| Q2 2025 | -1.23 | -1.12 | -9.79% | -30.85% | 1.031M | 131.753K | 682.52% | 158.40% |
| Q1 2025 | -1.04 | -0.96 | -8.34% | -11.83% | 361K | 92.728K | 289.31% | -43.59% |
| Q4 2024 | -0.88 | -0.91 | 2.94% | 2.22% | 738.113K | -100.00% | - | |
| Q3 2024 | -0.96 | -0.93 | -3.35% | 4.95% | 244.8K | -100.00% | -100.00% | |
| Q2 2024 | -0.94 | -0.88 | -7.29% | - | 399K | 520.2K | -23.30% | -59.62% |
| Q1 2024 | -0.93 | -0.83 | -12.64% | -9.41% | 640K | 260.671K | 145.52% | -76.11% |
| Q4 2023 | -0.90 | -0.88 | -2.31% | -7.14% | 265.2K | -100.00% | -100.00% | |
| Q3 2023 | -1.01 | -0.88 | -15.29% | -29.49% | 346K | 125.97K | 174.67% | -24.78% |
| Q2 2023 | -0.94 | -0.87 | -7.46% | -16.05% | 988K | 574.433K | 72.00% | 124.55% |
| Q1 2023 | -0.85 | -0.83 | -2.64% | -19.72% | 2.679M | 351.023K | 663.20% | -14.41% |
| Q4 2022 | -0.84 | -0.84 | -0.23% | -23.53% | 710K | 255K | 178.43% | -34.26% |
| Q3 2022 | -0.78 | -0.85 | 8.05% | -6.85% | 460K | 170.003K | 170.58% | - |
| Q2 2022 | -0.81 | -0.69 | -17.94% | -15.71% | 440K | 612K | -28.10% | - |
| Q1 2022 | -0.71 | -0.59 | -20.01% | -2.90% | 3.13M | 5.304M | -40.99% | - |
| Q4 2021 | -0.68 | -0.64 | -6.67% | -3.03% | 1.08M | - | - | |
| Q3 2021 | -0.73 | -0.73 | 0.04% | -30.36% | - | - | ||
| Q2 2021 | -0.70 | -0.62 | -12.50% | -32.08% | - | - | ||
| Q1 2021 | -0.69 | -0.67 | -2.50% | 2.82% | - | -100.00% | ||
| Q4 2020 | -0.66 | -0.59 | -11.95% | - | - | - | ||
| Q3 2020 | -0.56 | -0.54 | -4.38% | - | - | - | ||
| Q2 2020 | -0.53 | -0.58 | 8.20% | - | - | - | ||
| Q1 2020 | -0.71 | -0.64 | -10.49% | - | 70K | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-4.59%
Max EPS beat (4)
7.51%
Min EPS beat (4)
-9.79%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
234.47%
Max Revenue beat (4)
682.52%
Min Revenue beat (4)
-61.44%
Analysis
In the last 4 quarters, CRNX has beaten EPS estimates in 1 out of 4 releases
CRNX has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, CRNX reported -4.6% below the EPS estimates on average.
In the last 4 quarters, CRNX has beaten the revenue estimates by 234.5% on average.
Related analysis
CRINETICS PHARMACEUTICALS IN / CRNX Earnings FAQ
Can you provide information on whether CRINETICS PHARMACEUTICALS IN beat earnings estimates in the last quarter?
CRINETICS PHARMACEUTICALS IN (CRNX) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often CRINETICS PHARMACEUTICALS IN beats earnings estimates?
In the last 4 quarters, CRINETICS PHARMACEUTICALS IN (CRNX) has beaten EPS estimates in 1 out of 4 releases.